|
Code
|
5269C
|
|
MA number
|
EU/1/17/1225/001
|
|
Product Form:
|
tbl flm 30x800 mg/150 mg/200 mg/10 mg (fľ.HDPE)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Janssen - Cilag International N.V., Belgium
|
|
Therapeutic Class:
|
42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J05 |
ANTIVIRALS FOR SYSTEMIC USE |
| J05A |
DIRECT ACTING ANTIVIRALS |
| J05AR |
Antivirals for treatment of HIV infections, combinations |
| J05AR22 |
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat |
|
|
Shelf life:
|
36 |
|
Container:
|
bottle HDPE
|
|
Route of admin.:
|
Oral use
|
European Medicines Agency's database
